MassMutual Private Wealth & Trust FSB raised its holdings in JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 76.7% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 36,798 shares of the company’s stock after acquiring an additional 15,975 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in JPMorgan International Research Enhanced Equity ETF were worth $2,706,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Royal Bank of Canada boosted its position in JPMorgan International Research Enhanced Equity ETF by 80.6% in the 1st quarter. Royal Bank of Canada now owns 248,306 shares of the company’s stock valued at $15,820,000 after buying an additional 110,827 shares during the period. Goldman Sachs Group Inc. bought a new stake in JPMorgan International Research Enhanced Equity ETF during the first quarter valued at about $1,265,000. Geneos Wealth Management Inc. boosted its stake in JPMorgan International Research Enhanced Equity ETF by 124.8% in the first quarter. Geneos Wealth Management Inc. now owns 25,352 shares of the company’s stock valued at $1,615,000 after acquiring an additional 14,072 shares in the last quarter. HBW Advisory Services LLC boosted its position in shares of JPMorgan International Research Enhanced Equity ETF by 43.7% in the 2nd quarter. HBW Advisory Services LLC now owns 40,264 shares of the company’s stock worth $2,849,000 after purchasing an additional 12,245 shares in the last quarter. Finally, Lowe Wealth Advisors LLC grew its stake in shares of JPMorgan International Research Enhanced Equity ETF by 197.1% during the second quarter. Lowe Wealth Advisors LLC now owns 3,226 shares of the company’s stock worth $228,000 after acquiring an additional 2,140 shares during the last quarter.
JPMorgan International Research Enhanced Equity ETF Trading Down 0.4%
Shares of JPMorgan International Research Enhanced Equity ETF stock opened at $76.46 on Thursday. The firm’s 50 day simple moving average is $74.86 and its two-hundred day simple moving average is $73.14. JPMorgan International Research Enhanced Equity ETF has a 12-month low of $56.30 and a 12-month high of $76.95. The firm has a market capitalization of $10.22 billion, a price-to-earnings ratio of 16.04 and a beta of 0.82.
JPMorgan International Research Enhanced Equity ETF Company Profile
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Further Reading
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
